Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: May 2, 2000
Last updated: June 20, 2013
Last verified: August 2004